Luliconazole

CAS 187164-19-8

Overview

Luliconazole is a topical antifungal agent that acts by unknown mechanisms but is postulated to involve altering the synthesis of fungi cell membranes. It was approved by the FDA (USA) in November 2013 and is marketed under the brand name Luzu. Luliconazole is also approved in Japan

Anant Labs manufacture and furnish high quality Luliconazole impurities for global markets. Our Luliconazole EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.

In Stock

Luliconazole

CAS 187164-19-8In Stock

Technical Data

CAS187164-19-8

Mol. FormulaC₁₄H₉Cl₂N₃S₂

Mol. Weight354.287 g/mol

IUPAC(2E)-2-[(4R)-4-(2,4-dichlorophenyl)-1,3-dithiolan-2-ylidene]-2-imidazol-1-ylacetonitrile

SMILESC1[C@H](S/C(=C(\C#N)/N2C=CN=C2)/S1)C3=C(C=C(C=C3)Cl)Cl

InChIInChI=1S/C14H9Cl2N3S2/c15-9-1-2-10(11(16)5-9)13-7-20-14(21-13)12(6-17)19-4-3-18-8-19/h1-5,8,13H,7H2/b14-12+/t13-/m0/s1

InChI KeyYTAOBBFIOAEMLL-REQDGWNSSA-N

Note: We are upgrading our system, Cat No will change.

Synonyms

Luliconazole187164-19-8LuliconNND-502LuzuPR-2699NND502luliconazol(2E)-2-[(4R)-4-(2,4-dichlorophenyl)-1,3-dithiolan-2-ylidene]-2-imidazol-1-ylacetonitrileDTXSID3048607